Stefano Occhipinti
Papers
4
Total Citations
1,196
H-Index
4
About
Stefano Occhipinti is a leading urological surgeon and researcher whose work has fundamentally shaped the evidence base for robotic prostate cancer surgery. His primary research focus is the comparative effectiveness of robot-assisted laparoscopic prostatectomy (RALP) versus open radical retropubic prostatectomy (RRP) for localized prostate cancer. Occhipinti’s major contribution lies in conducting one of the first randomized controlled trials (RCTs) to directly compare these two surgical approaches. His landmark 2016 study, cited over 690 times, provided critical early outcomes from this phase 3 trial, demonstrating that RALP offers significant advantages in reducing perioperative morbidity, including lower blood loss and shorter hospital stays. This was followed by a highly influential 2018 paper (458 citations) reporting 24-month functional and oncological outcomes, further solidifying the evidence for robotic surgery’s role in improving recovery without compromising cancer control. Occhipinti’s pioneering RCT work has been instrumental in moving the field beyond retrospective comparisons, offering surgeons and patients high-quality data to inform treatment decisions. His contributions have made him a key figure in the global shift toward minimally invasive robotic prostatectomy.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4